Target intelligence / Profile preview

RNA, variant U1 small nuclear 18 (RNVU1-18)

Target
RNVU1-18
Molecular classification
Other (small nuclear RNA, variant U1 snRNA)
01

Overview

RNA, variant U1 small nuclear 18 (RNVU1-18) is a variant form of the small nuclear RNA (snRNA) U1, belonging to a family of highly homologous noncoding RNAs involved in the major spliceosome complex. Like canonical U1 snRNA, its primary biological function is the recognition of pre-mRNA 5' splice sites through base-pairing, a crucial step in the splicing of precursor mRNA transcripts. RNVU1-18 is annotated as a variant rather than canonical U1 snRNA gene and is found at the 1q21 chromosomal locus, often within segmental duplication regions, contributing to high interindividual structural variation and complex genomic architecture[2]. Mutations in RNVU1-18 and related U1 snRNAs have been observed recurrently in certain malignancies, most notably medulloblastoma and CLL, where they induce widespread aberrant RNA splicing and are associated with poorer prognosis. These mutations can disrupt correct splicing of critical oncogenes and tumor suppressors, and detection of such alterations is important for cancer diagnostics and prognostics. Despite its roles in splicing regulation and disease, RNVU1-18 is not a protein, receptor, enzyme, or druggable therapeutic target, but rather a noncoding RNA product critical to RNA processing[2][1][5].

Other names
vU1.18U1P101U1P15U1.15RNU1-25RNU1-25PRNU1-5RNU1P1RNU1P9RNA, U1 small nuclear 25, pseudogeneRNA, U1 small nuclear 5RNA, U1 small nuclear pseudogene 1RNA, U1 small nuclear pseudogene 9
02

Biological functions

Pre-mRNA splicing (splice site recognition)RNA processingregulation of splicing fidelity
03

Disease associations

Cancer (notably in medulloblastoma, chronic lymphocytic leukemia, and hepatocellular carcinoma, due to impact of mutations)Other (potentially impacts other diseases via splicing disruption)
04

Biomarkers

Mutations in RNVU1-18/U1 snRNA as a biomarker for prognosis and patient stratification in select cancers (e.g., medulloblastoma, CLL)

Beyond the preview

Go deeper on RNA, variant U1 small nuclear 18 (RNVU1-18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, variant U1 small nuclear 18 (RNVU1-18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call